Follow the 에이비온 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 에이비온 has published 6 insider filings. Market capitalisation: €62.9bn. The latest transaction was disclosed on 6 July 2026 (Purchase). Among the most active insiders: 우성윤. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
在XKRX市场上市的 에이비온 是一家健康和制药领域的公司。它专注于开发创新解决方案以改善医疗保健。